Neurodevelopmental outcomes of very low birth weight preterm infants treated with poractant alfa versus beractant for respiratory distress syndrome

American Journal of Perinatology

Volumn 31, Issue 6, 2014, Pages 463-468

  Eras, Zeynep ^a   Dizdar, Evrim Alyamac ^a   Kanmaz, Gozde ^a   Guzoglu, Nilufer ^a   Aksoy, Hatice Tatar ^a   Altunkaya, Gokce Baykal ^a   Canpolat, Fuat Emre ^a   Dilmen, Ugur ^a,b  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

beractant; neurodevelopmental outcome; poractant alfa; respiratory distress syndrome

Indexed keywords

BERACTANT; PORACTANT; BIOLOGICAL PRODUCT; LUNG SURFACTANT; PHOSPHOLIPID;

ARTICLE; CEREBRAL PALSY; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEWBORN ASSESSMENT; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VERY LOW BIRTH WEIGHT; CHILD DEVELOPMENT; COMPARATIVE STUDY; DRUG EFFECTS; NEUROPSYCHOLOGICAL TEST; NEWBORN; PREMATURE BIRTH; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TIME;

BIOLOGICAL PRODUCTS; CHILD DEVELOPMENT; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PHOSPHOLIPIDS; PREMATURE BIRTH; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TIME FACTORS;

EID: 84901689891     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1351659     Document Type: Article

References (31)

1. Anderson P. J., Doyle L. W. Cognitive and educational deficits in children born extremely preterm. Semin Perinatol: 2008; 32 1 51 58 (Pubitemid 351181451)
2. Aylward G. P. Neurodevelopmental outcomes of infants born prematurely. J Dev Behav Pediatr: 2005; 26 6 427 440 (Pubitemid 44384154)
3. Lemons J. A., Bauer C. R., Oh W., Korones S. B., Papille L. A., Stoll B. J., et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics: 2001; 107 1 E1
4. Ramanathan R. Choosing a right surfactant for respiratory distress syndrome treatment. Neonatology: 2009; 95 1 1 5
5. Seger N., Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev: 2009; 2 CD007836
6. Suresh G. K., Soll R. F. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents? Paediatr Drugs: 2002; 4 8 485 492 (Pubitemid 34876154)
7. Ramanathan R., Rasmussen M. R., Gerstmann D. R., Finer N., Sekar K. North American Study Group A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol: 2004; 21 3 109 119 (Pubitemid 38506904)
8. Malloy C. A., Nicoski P., Muraskas J. K. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr: 2005; 94 6 779 784 (Pubitemid 40839814)
9. Gerdes J. S., Seiberlich W., Sivieri E. M., et al. An open label comparison of calfactant and poractant alfa administration traits and impact on neonatal intensive care unit resources. J Pediatr Pharmacol Ther: 2006; 11 2 92 100
10. Singh N., Hawley K. L., Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics: 2011; 128 6 e1588 e1595
11. Ramanathan R. Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials. J Perinatol: 2009; 29 02 S38 S43
12. Barbarello-Andrews L., Marsh W. Pharmacoeconomics of surfactant therapy. J Pediatr Pharmacol Ther: 2006; 11 3 153 160
13. Marsh W., Smeeding J., York J. M., Ramanathan R., Sekar K. A cost minimization comparison of two surfactants-beractant and poractant alfa-based upon prospectively designed, comparative clinical trial data. J Pediatr Pharmacol Ther: 2004; 9 2 117 125
14. Dizdar E. A., Sari F. N., Aydemir C., et al. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome. Am J Perinatol: 2012; 29 2 95 100
15. Bayley N. Bayley Scales of Infant Development II. San Antonio, TX Psychological Corp: 1993
16. Hagberg B., Hagberg G., Olow I., von Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr: 1996; 85 8 954 960 (Pubitemid 26273842)
17. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr: 1978; 92 4 529 534 (Pubitemid 8293290)
18. Walsh M. C., Kliegman R. M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am: 1986; 33 1 179 201 (Pubitemid 16135483)
19. Ramanathan R., Bhatia J. J., Sekar K., Ernst F. R. Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, alfactant or beractant: a retrospective study. J Perinatol: 2013; 33 2 119 125
20. Fujii A. M., Patel S. M., Allen R., Doros G., Guo C. Y., Testa S. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J Perinatol: 2010; 30 10 665 670
21. Sinn J. K., Ward M. C., Henderson-Smart D. J. Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health: 2002; 38 6 597 600 (Pubitemid 35370569)
22. Auten R. L., Merzbach J., Myers G., Goldstein R. F., Palumbo D. Neurodevelopmental and health outcomes in term infants treated with surfactant for severe respiratory failure. J Perinatol: 2000; 20 5 291 294
23. Moya F., Sinha S., Gadzinowski J., et al. SELECT and STAR Study Investigators. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials. Pediatrics: 2007; 119 6 e1361 e1370 (Pubitemid 46871256)
24. Robertson B., Curstedt T., Tubman R., et al. Collaborative European Multicentre Study Group. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Eur J Pediatr: 1992; 151 5 372 376
25. Shankaran S., Johnson Y., Langer J. C., et al. Outcome of extremely-low-birth-weight infants at highest risk: gestational age < or = 24 weeks, birth weight < or =750. g, and 1-minute Apgar < or =3. Am J Obstet Gynecol: 2004; 191 4 1084 1091 (Pubitemid 39421555)
26. Moster D., Lie R. T., Markestad T. Joint association of Apgar scores and early neonatal symptoms with minor disabilities at school age. Arch Dis Child Fetal Neonatal Ed: 2002; 86 1 F16 F21 (Pubitemid 34074752)
27. McCrea H. J., Ment L. R. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol: 2008; 35 4 777 792, vii
28. O'Shea T. M., Allred E. N., Kuban K. C., et al. ELGAN Study Investigators. Intraventricular hemorrhage and developmental outcomes at 24 months of age in extremely preterm infants. J Child Neurol: 2012; 27 1 22 29
29. Morris B. H., Smith K. E., Swank P. R., Denson S. E., Landry S. H. Patterns of physical and neurologic development in preterm children. J Perinatol: 2002; 22 1 31 36 (Pubitemid 34162946)
30. Vollmer B., Roth S., Baudin J., Stewart A. L., Neville B. G., Wyatt J. S. Predictors of long-term outcome in very preterm infants: gestational age versus neonatal cranial ultrasound. Pediatrics: 2003; 112 5 1108 1114 (Pubitemid 37339565)
31. Fanaroff A. A., Stoll B. J., Wright L. L., et al. NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol: 2007; 196 2 e1 e8